SSC Subcommittee on Women's Health Issues in Thrombosis and Hemostasis

This SSC Subcommittee is focused on clinical syndromes of thrombosis and hemostasis related to women at various stages and/or associated with normal or complicated pregnancy or postpartum period. This SSC also focuses on the laboratory parameters of coagulation and fibrinolysis that are influenced by hormones which may vary in adolescent girls and pregnancy. This SSC incorporates hematologists, obstetricians and gynecologists, laboratory scientists, and epidemiologists.

If you are interested in the subcommittee and want to follow its activity, please click "join group" above to sign up as a member (follower).

Mandate

• To address issues of practical importance to the research community in the field.
• To evaluate existing data, determine issues for which data is missing or deficient, identify areas of controversy or pressing clinical need and discuss methodologic approaches to answer questions raised.
• To create international collaborations for the purpose of planning and executing projects related to the defined needs in the field.
• To suggest or organize collaborative studies as a result of these activities.
• To generate, publish and distribute communications, recommendations and other documents concerning the above.
• To develop laboratory standards, methods, and nomenclature if appropriate.

If you are a member of the Society and would like to know how to participate in the work of this group, please join the group to receive updates on activity or submit an Expression of Interest Form to the Chairman or any of the Co-Chairmen. We would be pleased to learn of your interest.

Leadership

• Chair - Offer Erez
• Co-chair - Robert Sidonio Jr.
• Co-chair - Eileen Merriman
• Co-chair - Angela Weyand
• Co-chair - Nadine Shehata
• Co-chair - Soledad Molnar
• Co-chair - Munira Borhany
• Co-chair - Marc Blondon
• Co-chair - Amihai Rottenstreich

Projects

• Understanding shared decision-making process regarding the choice of anticoagulant
  for pregnant patients with mechanical heart valves: an international qualitative research study project began: 2023, projected end: TBD
• PATH: Pregnancy-Associated Thrombosis, Hemorrhage, and Anemia, project began: 2025, projected end: TBD
• Practices regarding Heavy Menstrual Bleeding in Immune Thrombocytopenia, project began: 2024; projected end: TBD
• Racial Disparities in the Diagnostic Management and Outcomes of Pregnancy-associated Venous Thromboembolism: A Population-based Observational Study, project began: 2024, projected end:  2025
• International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT) Bleeding Score in Normal Children project began: 2023, projected end: 2024
• Current treatments practice in women with obstetric APS and women with obstetrical morbidity and “non-criteria” APS and adverse obstetrical outcomes: CORA international registry
  
  project began: 2021, projected end: 2024
• Failures in assIsted Reproductive Techniques (The FIRST Registry)
  project began: 2021, projected end: 2023; Complete e-CRF here
• International Registry on the Symptomatic Hemophilia A/B Carriers: The Pink Color of Hemophilia
  project began: 2023 projected end: 2025; See Registry here
• International Registry on Pregnancy and COVID-19 Associated Coagulopathy and Thrombosis
  project began: 2020, projected end: 2023; See Registry here

• Immune Thrombocytopenia and Obstetric Neuraxial Anesthesia at Low Platelet Counts – An International Registry
  project began: 2019, projected end: 2029;

• Registry for invasive treatments for massive pulmonary embolism in pregnancy and postpartum period
  project began: 2018, projected end 2027; See Registry here

Official Communications

• Minutes
• Bibliography
• Publication Guidelines